State Of Wyoming Blueprint Medicines Corp Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $73,860 - $114,554	1,633 Added 452.35%	1,994 $101,000
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $7,952 - $16,181	-147 Reduced 28.94%	361 $23,000
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $21,112 - $25,981	-224 Reduced 30.6%	508 $54,000
Q3 2021 Feb 11, 2022	SELL	$80.98 - $109.47 $22,917 - $30,980	-283 Reduced 27.88%	732 $75,000
Q2 2021 Feb 11, 2022	BUY	$82.78 - $101.0 $46,191 - $56,358	558 Added 122.1%	1,015 $89,000
Q1 2021 Feb 08, 2022	BUY	$90.71 - $108.28 $41,454 - $49,483	457 New	457 $44,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.